Woodline Partners LP Immatics N.V. Transaction History

Woodline Partners LP

  • $17.6 Billion
  • Q2 2025

A detailed history of Woodline Partners LP transactions in Immatics N.V. stock. As of the latest transaction made, Woodline Partners LP holds 3,877,631 shares of IMTX stock, worth $22.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,877,631
Previous 1,684,285 130.22%
Holding current value
$22.5 Million
Previous $7.6 Million 174.63%
% of portfolio
0.12%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$3.5 - $6.14 $7.68 Million - $13.5 Million
2,193,346 Added 130.22%
3,877,631 $20.9 Million
Q1 2025

May 15, 2025
SELL
$4.18 - $7.42 $1.46 Million - $2.6 Million
-349,939 Reduced 17.2%
1,684,285 $7.6 Million
Q4 2024

Feb 14, 2025
SELL
$6.73 - $11.21 $3.15 Million - $5.24 Million
-467,738 Reduced 18.69%
2,034,224 $14.5 Million
Q3 2024

Nov 14, 2024
SELL
$10.93 - $12.92 $8.31 Million - $9.82 Million
-760,048 Reduced 23.3%
2,501,962 $28.5 Million
Q2 2024

Aug 14, 2024
BUY
$9.78 - $13.49 $8.68 Million - $12 Million
888,023 Added 37.41%
3,262,010 $37.9 Million
Q1 2024

May 15, 2024
BUY
$10.23 - $12.94 $3.11 Million - $3.93 Million
303,904 Added 14.68%
2,373,987 $25 Million
Q4 2023

Feb 14, 2024
SELL
$7.36 - $10.89 $2.43 Million - $3.59 Million
-329,917 Reduced 13.75%
2,070,083 $21.8 Million
Q3 2023

Nov 14, 2023
BUY
$11.01 - $12.62 $13.1 Million - $15 Million
1,186,116 Added 97.71%
2,400,000 $27.8 Million
Q2 2023

Aug 14, 2023
BUY
$5.92 - $12.72 $1.4 Million - $3 Million
235,922 Added 24.12%
1,213,884 $14 Million
Q1 2023

May 15, 2023
BUY
$6.74 - $9.44 $6.59 Million - $9.23 Million
977,962 New
977,962 $6.75 Million
Q2 2022

Aug 15, 2022
SELL
$6.0 - $9.37 $1.92 Million - $2.99 Million
-319,480 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$6.64 - $12.85 $2.82 Million - $5.45 Million
-424,010 Reduced 57.03%
319,480 $2.55 Million
Q4 2021

Feb 14, 2022
BUY
$10.81 - $14.38 $1.49 Million - $1.98 Million
137,570 Added 22.7%
743,490 $9.99 Million
Q3 2021

Nov 15, 2021
BUY
$11.58 - $15.46 $659,978 - $881,111
56,993 Added 10.38%
605,920 $7.88 Million
Q2 2021

Aug 16, 2021
SELL
$10.43 - $12.81 $529,072 - $649,800
-50,726 Reduced 8.46%
548,927 $6.37 Million
Q1 2021

May 17, 2021
BUY
$10.24 - $14.6 $905,185 - $1.29 Million
88,397 Added 17.29%
599,653 $6.72 Million
Q4 2020

Feb 16, 2021
BUY
$9.67 - $12.05 $3.14 Million - $3.91 Million
324,665 Added 174.0%
511,256 $5.52 Million
Q3 2020

Nov 16, 2020
BUY
$8.73 - $15.15 $1.63 Million - $2.83 Million
186,591 New
186,591 $1.98 Million

Others Institutions Holding IMTX

# of Institutions
74
Shares Held
93.6M
Call Options Held
158K
Put Options Held
0
View Full List

About Immatics N.V.

IMTX Quotes by TradingView
  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $443M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email